NASDAQ:OACCU Oaktree Acquisition Corp. III Life Sciences (OACCU) Stock Price, News & Analysis $10.82 +0.14 (+1.35%) As of 03:54 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Oaktree Acquisition Corp. III Life Sciences Stock (NASDAQ:OACCU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get OACCU alerts:Sign Up Key Stats Today's Range$10.68▼$10.6850-Day Range$10.63▼$10.9052-Week Range$10.12▼$11.06Volume38 shsAverage Volume467 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Oaktree Acquisition Corp. III Life Sciences (NASDAQ: OACCU) is a special purpose acquisition company formed to target businesses in the life sciences sector. As a blank‐check vehicle, the company raises capital through an initial public offering with the purpose of acquiring or merging with one or more operating companies. Its focus areas include biotechnology, pharmaceuticals, medical devices and healthcare services. Established in Delaware and sponsored by affiliates of Oaktree Capital Management, OACCU leverages the resources and investment expertise of one of the world’s leading alternative asset managers. The company’s structure allows it to seek out emerging and established life science enterprises that can benefit from public market access and strategic guidance. OACCU intends to complete its initial business combination within the timeframe prescribed by its governing charter, typically within two years of the IPO. During this period, the management team evaluates potential targets primarily in North America, though it retains the flexibility to consider opportunities globally. The company’s blank‐check format provides shareholders with the right to redeem their shares if they do not approve of a proposed transaction. The leadership team at Oaktree Acquisition Corp. III Life Sciences comprises professionals drawn from Oaktree Capital Management and seasoned executives in the healthcare and life sciences industries. Their combined backgrounds in finance, research and corporate development are directed toward identifying high‐growth companies that can scale through strategic partnerships, operational improvements and access to public capital markets.AI Generated. May Contain Errors. Read More Receive OACCU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oaktree Acquisition Corp. III Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OACCU Stock News HeadlinesOaktree Acquisition Appoints Dr. Berry as DirectorOctober 17, 2025 | tipranks.comSee More Headlines OACCU Stock Analysis - Frequently Asked Questions How have OACCU shares performed this year? Oaktree Acquisition Corp. III Life Sciences' stock was trading at $10.61 at the start of the year. Since then, OACCU stock has increased by 2.0% and is now trading at $10.8240. When did Oaktree Acquisition Corp. III Life Sciences IPO? Oaktree Acquisition Corp. III Life Sciences (OACCU) raised $175 million in an IPO on Thursday, October 24th 2024. The company issued 17,500,000 shares at a price of $10.00 per share. Jefferies, Citigroup and UBS Investment Bank acted as the underwriters for the IPO. Who are Oaktree Acquisition Corp. III Life Sciences' major shareholders? Oaktree Acquisition Corp. III Life Sciences' top institutional investors include DLD Asset Management LP. How do I buy shares of Oaktree Acquisition Corp. III Life Sciences? Shares of OACCU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 OACCU's financial health is in the Green zone, according to TradeSmith. OACCU has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorFinance Industry Investment Offices Sub-IndustryTrading Current SymbolNASDAQ:OACCU CIK2029769 WebN/A Phone(213) 830-6300FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableN/A BetaN/A 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NASDAQ:OACCU) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. III Life Sciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition Corp. III Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.